MedTrace Logo

Repetitive Transcranial Magnetic Stimulation (rTMS) in Depression

NCT00920322 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-07-21

No results posted yet for this study

Summary

This study will report on the outcomes of rTMS administered 3 times per week, compared with the standard protocol of 5 times per week. Participants will be randomly assigned to frequency condition and depressive symptomatology will be measured weekly using a range of clinician and self-rated questionnaires. Participants will remain in the study for at least 4 weeks, with the option of continuing for a further 2 weeks as judged by the study psychiatrist. It is hypothesised that rTMS administered three times per week will be equally as effective as rTMS administered five times per week in reducing depressive symptomatology.

Conditions

Interventions

DEVICE

rTMS 5 x weekly

Patients will receive rTMS five times weekly for 4 weeks

DEVICE

rTMS 3 times weekly

Patients will receive rTMS 3 times weekly for 4 weeks

Sponsors & Collaborators

  • Northside Clinic, Australia

    lead OTHER

Principal Investigators

  • Colleen Loo, MBBS, FRANZCP, MD · University of NSW

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00920322 on ClinicalTrials.gov